BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 18757402)

  • 1. Inflammatory cytokines induce phosphorylation and ubiquitination of prostate suppressor protein NKX3.1.
    Markowski MC; Bowen C; Gelmann EP
    Cancer Res; 2008 Sep; 68(17):6896-901. PubMed ID: 18757402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proline-mediated proteasomal degradation of the prostate-specific tumor suppressor NKX3.1.
    Rao V; Guan B; Mutton LN; Bieberich CJ
    J Biol Chem; 2012 Oct; 287(43):36331-40. PubMed ID: 22910912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Tumor Suppressor NKX3.1 Is Targeted for Degradation by DYRK1B Kinase.
    Song LN; Silva J; Koller A; Rosenthal A; Chen EI; Gelmann EP
    Mol Cancer Res; 2015 May; 13(5):913-22. PubMed ID: 25777618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of PTEN Accelerates NKX3.1 Degradation to Promote Prostate Cancer Progression.
    Bowen C; Ostrowski MC; Leone G; Gelmann EP
    Cancer Res; 2019 Aug; 79(16):4124-4134. PubMed ID: 31213464
    [No Abstract]   [Full Text] [Related]  

  • 5. Ubiquitination by TOPORS regulates the prostate tumor suppressor NKX3.1.
    Guan B; Pungaliya P; Li X; Uquillas C; Mutton LN; Rubin EH; Bieberich CJ
    J Biol Chem; 2008 Feb; 283(8):4834-40. PubMed ID: 18077445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical and functional interactions between the prostate suppressor homeoprotein NKX3.1 and serum response factor.
    Ju JH; Maeng JS; Zemedkun M; Ahronovitz N; Mack JW; Ferretti JA; Gelmann EP; Gruschus JM
    J Mol Biol; 2006 Jul; 360(5):989-99. PubMed ID: 16814806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stabilization of the prostate-specific tumor suppressor NKX3.1 by the oncogenic protein kinase Pim-1 in prostate cancer cells.
    Padmanabhan A; Gosc EB; Bieberich CJ
    J Cell Biochem; 2013 May; 114(5):1050-7. PubMed ID: 23129228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulating NKX3.1 stability and function: Post-translational modifications and structural determinants.
    Padmanabhan A; Rao V; De Marzo AM; Bieberich CJ
    Prostate; 2016 May; 76(6):523-33. PubMed ID: 26841725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen regulation of the prostatic tumour suppressor NKX3.1 is mediated by its 3' untranslated region.
    Thomas MA; Preece DM; Bentel JM
    Biochem J; 2010 Jan; 425(3):575-83. PubMed ID: 19886863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occurrence of NKX3.1 C154T polymorphism in men with and without prostate cancer and studies of its effect on protein function.
    Gelmann EP; Steadman DJ; Ma J; Ahronovitz N; Voeller HJ; Swope S; Abbaszadegan M; Brown KM; Strand K; Hayes RB; Stampfer MJ
    Cancer Res; 2002 May; 62(9):2654-9. PubMed ID: 11980664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional activation of ATM by the prostate cancer suppressor NKX3.1.
    Bowen C; Ju JH; Lee JH; Paull TT; Gelmann EP
    Cell Rep; 2013 Aug; 4(3):516-29. PubMed ID: 23890999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR/Cas9-Mediated Point Mutation in
    Bowen C; Shibata M; Zhang H; Bergren SK; Shen MM; Gelmann EP
    Cancer Res; 2020 Nov; 80(21):4805-4814. PubMed ID: 32943441
    [No Abstract]   [Full Text] [Related]  

  • 13. TNFα-mediated loss of β-catenin/E-cadherin association and subsequent increase in cell migration is partially restored by NKX3.1 expression in prostate cells.
    Debelec-Butuner B; Alapinar C; Ertunc N; Gonen-Korkmaz C; Yörükoğlu K; Korkmaz KS
    PLoS One; 2014; 9(10):e109868. PubMed ID: 25360740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of the acidic domain and SRF interacting motifs with the NKX3.1 homeodomain.
    Ju JH; Maeng JS; Lee DY; Piszczek G; Gelmann EP; Gruschus JM
    Biochemistry; 2009 Nov; 48(44):10601-7. PubMed ID: 19780584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NKX3.1 is regulated by protein kinase CK2 in prostate tumor cells.
    Li X; Guan B; Maghami S; Bieberich CJ
    Mol Cell Biol; 2006 Apr; 26(8):3008-17. PubMed ID: 16581776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammation-mediated abrogation of androgen signaling: an in vitro model of prostate cell inflammation.
    Debelec-Butuner B; Alapinar C; Varisli L; Erbaykent-Tepedelen B; Hamid SM; Gonen-Korkmaz C; Korkmaz KS
    Mol Carcinog; 2014 Feb; 53(2):85-97. PubMed ID: 22911881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nkx3.1 functions as para-transcription factor to regulate gene expression and cell proliferation in non-cell autonomous manner.
    Zhou J; Qin L; Tien JC; Gao L; Chen X; Wang F; Hsieh JT; Xu J
    J Biol Chem; 2012 May; 287(21):17248-17256. PubMed ID: 22465996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional regulation of the
    Xie Q; Wang ZA
    J Biol Chem; 2017 Aug; 292(33):13521-13530. PubMed ID: 28679531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germ-line mutation of NKX3.1 cosegregates with hereditary prostate cancer and alters the homeodomain structure and function.
    Zheng SL; Ju JH; Chang BL; Ortner E; Sun J; Isaacs SD; Sun J; Wiley KE; Liu W; Zemedkun M; Walsh PC; Ferretti J; Gruschus J; Isaacs WB; Gelmann EP; Xu J
    Cancer Res; 2006 Jan; 66(1):69-77. PubMed ID: 16397218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion, methylation, and expression of the NKX3.1 suppressor gene in primary human prostate cancer.
    Asatiani E; Huang WX; Wang A; Rodriguez Ortner E; Cavalli LR; Haddad BR; Gelmann EP
    Cancer Res; 2005 Feb; 65(4):1164-73. PubMed ID: 15734999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.